These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology. Engelmayr GC; Soletti L; Vigmostad SC; Budilarto SG; Federspiel WJ; Chandran KB; Vorp DA; Sacks MS Ann Biomed Eng; 2008 May; 36(5):700-12. PubMed ID: 18253834 [TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan entrapment by fibrin in engineered heart valve tissues. Alfonso AR; Rath S; Rafiee P; Hernandez-Espino M; Din M; George F; Ramaswamy S Acta Biomater; 2013 Sep; 9(9):8149-57. PubMed ID: 23791855 [TBL] [Abstract][Full Text] [Related]
5. Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype. Rath S; Salinas M; Villegas AG; Ramaswamy S PLoS One; 2015; 10(11):e0141802. PubMed ID: 26536240 [TBL] [Abstract][Full Text] [Related]
6. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Ramaswamy S; Gottlieb D; Engelmayr GC; Aikawa E; Schmidt DE; Gaitan-Leon DM; Sales VL; Mayer JE; Sacks MS Biomaterials; 2010 Feb; 31(6):1114-25. PubMed ID: 19944458 [TBL] [Abstract][Full Text] [Related]
7. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464 [TBL] [Abstract][Full Text] [Related]
8. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
11. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing? Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371 [TBL] [Abstract][Full Text] [Related]
13. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering. VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518 [TBL] [Abstract][Full Text] [Related]
14. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792 [TBL] [Abstract][Full Text] [Related]
15. A "sweet-spot" for fluid-induced oscillations in the conditioning of stem cell-based engineered heart valve tissues. Williams A; Nasim S; Salinas M; Moshkforoush A; Tsoukias N; Ramaswamy S J Biomech; 2017 Dec; 65():40-48. PubMed ID: 29054608 [TBL] [Abstract][Full Text] [Related]
16. TGF-β-operated growth inhibition and translineage commitment into smooth muscle cells of periodontal ligament-derived endothelial progenitor cells through Smad- and p38 MAPK-dependent signals. Yoshida M; Okubo N; Chosa N; Hasegawa T; Ibi M; Kamo M; Kyakumoto S; Ishisaki A Int J Biol Sci; 2012; 8(7):1062-74. PubMed ID: 22949889 [TBL] [Abstract][Full Text] [Related]
17. A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions. Ramaswamy S; Boronyak SM; Le T; Holmes A; Sotiropoulos F; Sacks MS J Biomech Eng; 2014 Dec; 136(12):121009. PubMed ID: 25321615 [TBL] [Abstract][Full Text] [Related]
18. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Mol A; Driessen NJ; Rutten MC; Hoerstrup SP; Bouten CV; Baaijens FP Ann Biomed Eng; 2005 Dec; 33(12):1778-88. PubMed ID: 16389526 [TBL] [Abstract][Full Text] [Related]
19. Computational simulations predict a key role for oscillatory fluid shear stress in de novo valvular tissue formation. Salinas M; Ramaswamy S J Biomech; 2014 Nov; 47(14):3517-23. PubMed ID: 25262874 [TBL] [Abstract][Full Text] [Related]
20. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]